Priority Date: 27.01.12 (EP 20120152934)

RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF DUCHENNE AND BECKER MUSCULAR DYSTROPHY

  • Application ID: EP13704832
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.01.2012 - Priority Date (EP 20120152934)
  • 01.08.2013 - Publication A1 (WO2013112053)
  • 03.12.2014 - Publication A1 (EP2806900)

IPC Classification